Evaluated articles

Showing page 1086 of 1181 pages of list content

The effect of population mobility restrictive measures on the incidence of SARS-CoV-2 infection in the early phase of the pandemic

This article has 3 authors:
1. Luis Gustavo Modelli de Andrade
2. Gustavo Fernandes Ferreira
3. Helio Tedesco-Silva
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 19, 2021Latest activity Apr 24, 2021
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

This article has 33 authors:
1. Susanna Croci
2. Mary Anna Venneri
3. Stefania Mantovani
4. Chiara Fallerini
5. Elisa Benetti
6. Nicola Picchiotti
7. Federica Campolo
8. Francesco Imperatore
9. Maria Palmieri
10. Sergio Daga
11. Chiara Gabbi
12. Francesca Montagnani
13. Giada Beligni
14. Ticiana D.J. Farias
15. Miriam Lucia Carriero
16. Laura Di Sarno
17. Diana Alaverdian
18. Sigrid Aslaksen
19. Maria Vittoria Cubellis
20. Ottavia Spiga
21. Margherita Baldassarri
22. Francesca Fava
23. Paul J. Norman
24. Elisa Frullanti
25. Andrea M. Isidori
26. Antonio Amoroso
27. Francesca Mari
28. Simone Furini
29. Mario U Mondelli
30. GEN-COVID multicenter study
31. Mario Chiariello
32. Alessandra Renieri
33. Ilaria Meloni
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 29, 2021Latest activity Mar 29, 2021
Do examinations prepare students for higher education? A lesson from the Covid-19 lockdown

This article has 5 authors:
1. Harriet L. Jones
2. Valentina Zini
3. Jon R. Green
4. John R. Prendergast
5. Jon Scott
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 30, 2021Latest activity Mar 1, 2021
Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics

This article has 8 authors:
1. Jana L Hirschtick
2. Andrea R Titus
3. Elizabeth Slocum
4. Laura E Power
5. Robert E Hirschtick
6. Michael R Elliott
7. Patricia McKane
8. Nancy L Fleischer
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 19, 2021Latest activity Mar 15, 2021
Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro

This article has 18 authors:
1. Yeh Chen
2. Wen-Hao Yang
3. Li-Min Huang
4. Yu-Chuan Wang
5. Chia-Shin Yang
6. Yi-Liang Liu
7. Mei-Hui Hou
8. Chia-Ling Tsai
9. Yi-Zhen Chou
10. Bao-Yue Huang
11. Chian-Fang Hung
12. Yu-Lin Hung
13. Jin-Shing Chen
14. Yu-Ping Chiang
15. Der-Yang Cho
16. Long-Bin Jeng
17. Chang-Hai Tsai
18. Mien-Chie Hung
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Aug 15, 2020Latest activity Mar 1, 2021
Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential

This article has 7 authors:
1. Divya Gupta
2. Haripriya Parthasarathy
3. Vishal Sah
4. Dixit Tandel
5. Dhiviya Vedagiri
6. Shashikala Reddy
7. Krishnan H Harshan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2021Latest activity Apr 26, 2021
The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV

This article has 3 authors:
1. Mihkel Örd
2. Ilona Faustova
3. Mart Loog
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 9, 2020Latest activity Mar 1, 2021
Covid-19 and excess mortality in medicare beneficiaries

This article has 7 authors:
1. Scott D. Greenwald
2. Nassib G. Chamoun
3. Paul J. Manberg
4. Josh Gray
5. David Clain
6. Kamal Maheshwari
7. Daniel I. Sessler
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 2, 2022Latest activity Apr 14, 2021
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity

This article has 30 authors:
1. Lisa R. Volpatti
2. Rachel P. Wallace
3. Shijie Cao
4. Michal M. Raczy
5. Ruyi Wang
6. Laura T. Gray
7. Aaron T. Alpar
8. Priscilla S. Briquez
9. Nikolaos Mitrousis
10. Tiffany M. Marchell
11. Maria Stella Sasso
12. Mindy Nguyen
13. Aslan Mansurov
14. Erica Budina
15. Ani Solanki
16. Elyse A. Watkins
17. Mathew R. Schnorenberg
18. Andrew C. Tremain
19. Joseph W. Reda
20. Vlad Nicolaescu
21. Kevin Furlong
22. Steve Dvorkin
23. Shann S. Yu
24. Balaji Manicassamy
25. James L. LaBelle
26. Matthew V. Tirrell
27. Glenn Randall
28. Marcin Kwissa
29. Melody A. Swartz
30. Jeffrey A. Hubbell
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 21, 2021Latest activity Apr 10, 2021
Supramolecular Cylinders Target Bulge Structures in the 5′ UTR of the RNA Genome of SARS‐CoV‐2 and Inhibit Viral Replication**

This article has 15 authors:
1. Lazaros Melidis
2. Harriet J. Hill
3. Nicholas J. Coltman
4. Scott P. Davies
5. Kinga Winczura
6. Tasha Chauhan
7. James S. Craig
8. Aditya Garai
9. Catherine A. J. Hooper
10. Ross T. Egan
11. Jane A. McKeating
12. Nikolas J. Hodges
13. Zania Stamataki
14. Pawel Grzechnik
15. Michael J. Hannon
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 9, 2021Latest activity Apr 2, 2021
Flocked swab might be one main reason causing the high false-negative rate in COVID-19 screening----the advantages of a novel silicone swab

This article has 11 authors:
1. Jianye Zhou
2. Zhongtian Bai
3. Xiaoping Liu
4. Yaqiong Guo
5. Nan Jiang
6. Xiaodong Li
7. Xiaohui Zhang
8. Zhiqiang Li
9. Yonghong Li
10. Zhongren Ma
11. Jin Zhao
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 30, 2020Latest activity Mar 1, 2021
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters

This article has 14 authors:
1. Rebecca L. Brocato
2. Lucia M. Principe
3. Robert K. Kim
4. Xiankun Zeng
5. Janice A. Williams
6. Yanan Liu
7. Rong Li
8. Jeffrey M. Smith
9. Joseph W. Golden
10. Dave Gangemi
11. Sawsan Youssef
12. Zhongde Wang
13. Jacob Glanville
14. Jay W. Hooper
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Oct 27, 2020Latest activity Mar 1, 2021
Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology

This article has 19 authors:
1. Amit Kumar Singh
2. Nandini Kasarpalkar
3. Shilpa Bhowmick
4. Gaurav Paradkar
5. Mayur Talreja
6. Karan Shah
7. Abhishek Tiwari
8. Harsha Palav
9. Snehal Kaginkar
10. Rajiv Kulkarni
11. Ashwini Patil
12. Varsha Kalsurkar
13. Sachee Agrawal
14. Jayanthi Shastri
15. Rajesh Dere
16. Ramesh Bharmal
17. Smita D Mahale
18. Vikrant M Bhor
19. Vainav Patel
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 24, 2022Latest activity Apr 1, 2021
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

This article has 14 authors:
1. Satoshi Ikegame
2. Mohammed N. A. Siddiquey
3. Chuan-Tien Hung
4. Griffin Haas
5. Luca Brambilla
6. Kasopefoluwa Y. Oguntuyo
7. Shreyas Kowdle
8. Hsin-Ping Chiu
9. Christian S. Stevens
10. Ariel Esteban Vilardo
11. Alexis Edelstein
12. Claudia Perandones
13. Jeremy P. Kamil
14. Benhur Lee
Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

This article has 4 evaluationsAppears in 2 listsLatest version Jul 26, 2021Latest activity May 29, 2021
High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape

This article has 15 authors:
1. Franz-Josef Obermair
2. Florian Renoux
3. Sebastian Heer
4. Chloe H. Lee
5. Nastassja Cereghetti
6. Marisa Loi
7. Giulia Maestri
8. Yannick Haldner
9. Robin Wuigk
10. Ohad Iosefson
11. Pooja Patel
12. Katherine Triebel
13. Manfred Kopf
14. Joanna Swain
15. Jan Kisielow
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 29, 2022Latest activity Mar 15, 2021
Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

This article has 23 authors:
1. Kouji Kobiyama
2. Masaki Imai
3. Nao Jounai
4. Misako Nakayama
5. Kou Hioki
6. Kiyoko Iwatsuki-Horimoto
7. Seiya Yamayoshi
8. Jun Tsuchida
9. Takako Niwa
10. Takashi Suzuki
11. Mutsumi Ito
12. Shinya Yamada
13. Tokiko Watanabe
14. Maki Kiso
15. Hideo Negishi
16. Burcu Temizoz
17. Hirohito Ishigaki
18. Yoshinori Kitagawa
19. Cong Thanh Nguyen
20. Yasushi Itoh
21. Fumihiko Takeshita
22. Yoshihiro Kawaoka
23. Ken J. Ishii
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 4, 2021Latest activity Mar 15, 2021
In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial

This article has 7 authors:
1. Rola Elzein
2. Fadi Abdel-Sater
3. Soha Fakhreddine
4. Pierre Abi Hanna
5. Rita Feghali
6. Hassan Hamad
7. Fouad Ayoub
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 1, 2021Latest activity Mar 24, 2021
Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines—An Open Access, Stochastic Simulation Tool

This article has 4 authors:
1. Wolfram A. Bosbach
2. Martin Heinrich
3. Rainer Kolisch
4. Christian Heiss
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 22, 2021Latest activity Mar 15, 2021
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

This article has 10 authors:
1. Takuya Tada
2. Belinda M. Dcosta
3. Marie I. Samanovic
4. Ramin S. Herati
5. Amber Cornelius
6. Hao Zhou
7. Ada Vaill
8. Wes Kazmierski
9. Mark J. Mulligan
10. Nathaniel R. Landau
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jun 29, 2021Latest activity Mar 1, 2021
Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine

This article has 9 authors:
1. Gajanan Sapkal
2. Pragya D. Yadav
3. Raches Ella
4. Priya Abraham
5. Deepak Y. Patil
6. Nivedita Gupta
7. Samiran Panda
8. V. Krishna Mohan
9. Balram Bhargava
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 30, 2021Latest activity May 2, 2021

Evaluated articles

The effect of population mobility restrictive measures on the incidence of SARS-CoV-2 infection in the early phase of the pandemic

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

Do examinations prepare students for higher education? A lesson from the Covid-19 lockdown

Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics

Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2 main protease by tafenoquine in vitro

Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential

The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV

Covid-19 and excess mortality in medicare beneficiaries

Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity

Supramolecular Cylinders Target Bulge Structures in the 5′ UTR of the RNA Genome of SARS‐CoV‐2 and Inhibit Viral Replication**

Flocked swab might be one main reason causing the high false-negative rate in COVID-19 screening----the advantages of a novel silicone swab

Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters

Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape

Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial

Maximization of Open Hospital Capacity under Shortage of SARS-CoV-2 Vaccines—An Open Access, Stochastic Simulation Tool

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine